XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Other income (expense) (Tables)
9 Months Ended
Sep. 30, 2023
Analysis of income and expense [abstract]  
Disclosure Of Detailed Information About Financial Income Explanatory
The components of financial income for the three and nine months ended September 30, 2023 and September 30, 2022 are as follows:
Three months ended September 30,Nine months ended September 30,
(in KUSD)Note2023202220232022
Interest income2,703 273 7,250 309 
Cumulative catch-up adjustment, deferred royalty obligation17437 — — 18,288 
Financial income3,140 273 7,250 18,597 
Disclosure Of Detailed Information About Financial Expense Explanatory
The components of financial expense for the three and nine months ended September 30, 2023 and September 30, 2022 are as follows:
Three months ended September 30,Nine months ended September 30,
(in KUSD)Note2023202220232022
Cumulative catch-up adjustment, deferred royalty obligation17— 2,175 4,851 2,255 
Deferred royalty obligation interest expense178,087 5,669 19,662 17,356 
Effective interest expense on senior secured term loan facility134,728 1,933 13,748 1,933 
Effective interest expense on convertible loans14— 1,536 — 7,684 
Interest expense on leasing and other12127 43 389 146 
Financial expense12,942 11,356 38,650 29,374 
Schedule of Other income (expense) The components of non-operating expense for the three and nine months ended September 30, 2023 and September 30, 2022 are as follows:
Three months ended September 30,Nine months ended September 30,
(in KUSD)Note2023202220232022
Convertible loans, derivatives, change in fair value (expense) income14— (4,660)— 25,650 
Loss on debt extinguishment14— (42,114)— (42,114)
Deerfield warrant obligation, change in fair value income15140 9,418 776 9,418 
Senior secured term loan facility, warrants, transaction costs13— (245)— (245)
Senior secured term loan facility, warrants, change in fair value income13299 2,543 916 2,543 
Share of results with joint venture11(1,409)(2,130)(3,539)(6,549)
Exchange differences gain (loss)39 (56)248 
R&D tax credit244 122 699 244 
Non-operating expense(687)(37,122)(1,143)(10,805)